000			01972 a2200553 4500
005			20250513184551.0
264		0	_c19990630
008			199906s 0 0 eng d
022			_a0950-9232
024	7		_a10.1038/sj.onc.1202700 _2doi
040			_aNLM _beng _cNLM
100	1		_aDaly, J M
245	0	0	_aNDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways. _h[electronic resource]
260			_bOncogene _cJun 1999
300			_a3440-51 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCSK Tyrosine-Protein Kinase
650	0	4	_aCalcium-Calmodulin-Dependent Protein Kinases _xphysiology
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aEnzyme Activation
650	0	4	_aEpidermal Growth Factor _xmetabolism
650	0	4	_aErbB Receptors _xmetabolism
650	0	4	_aG1 Phase _xdrug effects
650	0	4	_aG2 Phase _xdrug effects
650	0	4	_aGlycoproteins _xpharmacology
650	0	4	_aHumans
650	0	4	_aMitogen-Activated Protein Kinases
650	0	4	_aNeuregulins
650	0	4	_aPhosphatidylinositol 3-Kinases _xphysiology
650	0	4	_aProtein-Tyrosine Kinases _xmetabolism
650	0	4	_aProto-Oncogene Proteins _xmetabolism
650	0	4	_aReceptor, ErbB-2 _xmetabolism
650	0	4	_aReceptor, ErbB-3
650	0	4	_aSignal Transduction
650	0	4	_aTumor Cells, Cultured
650	0	4	_ap38 Mitogen-Activated Protein Kinases
650	0	4	_asrc-Family Kinases
700	1		_aOlayioye, M A
700	1		_aWong, A M
700	1		_aNeve, R
700	1		_aLane, H A
700	1		_aMaurer, F G
700	1		_aHynes, N E
773	0		_tOncogene _gvol. 18 _gno. 23 _gp. 3440-51
856	4	0	_uhttps://doi.org/10.1038/sj.onc.1202700 _zAvailable from publisher's website
999			_c10334968 _d10334968